Researchers employ Hexarelin Acetate to investigate its exceptional potency as a GHS-R1a agonist, resulting in GH pulses significantly exceeding those of earlier secretagogues. Pre-clinical findings in pituitary cell cultures and animal models indicate robust stimulation of GH secretion through Gq/PLC and calcium-dependent pathways, with additional binding to CD36 receptors conferring tissue-protective properties.
This hexapeptide facilitates examination of maximal somatotropic axis activation, receptor-mediated cardioprotection, and potential metabolic interactions in stress-challenged research paradigms.
Scientific Overview of Hexarelin Acetate Applications
Pre-clinical models demonstrate Hexarelin Acetate’s engagement with secretagogue and cardioprotective mechanisms:
- Potent activation of GHS-R1a leading to GH release 10–15× baseline in acute administration studies. https://pubmed.ncbi.nlm.nih.gov/7957536/
- Synergistic amplification of GH response when combined with GHRH in pituitary models, enhancing pulsatile secretion profiles. https://pubmed.ncbi.nlm.nih.gov/8706295/
- Direct binding to CD36 receptors, contributing to cardioprotective effects including reduced infarct size in ischemia-reperfusion models. https://pmc.ncbi.nlm.nih.gov/articles/PMC4178518/
- Stimulation of phosphatidylinositol turnover and PKC/Ca2+ cascades in bovine and human somatotroph systems. https://pubmed.ncbi.nlm.nih.gov/9331879/
- Modulation of ACTH and cortisol responses in pituitary cell assays, with distinct patterns compared to other GHRPs. https://pubmed.ncbi.nlm.nih.gov/19682503/
- Examination of cytoprotective actions in cardiac and extra-cardiac tissues under stress or toxin exposure.
For additional context on growth hormone secretagogues, GHS-R1a/CD36 dual agonism, and cardioprotective signaling in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs Hexarelin Acetate
National Science Labs manufactures Hexarelin Acetate under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your Hexarelin Acetate Research Protocol
Source high-purity Hexarelin Acetate from current limited batches to ensure optimal stability and performance in growth hormone secretagogue and cardioprotective signaling studies.
